DVAX Gets Some COVID-19 News That is Not Hype

I hold DVAX because of its Hep vaccine rollout and commercialization. A bet that they can execute. While the COVID-19 hype it has received along the way has produced profitable trades, today’s hype is in response to something that seems material and makes me glad I held some after the last sale.

Yay! Let’s hear it for the little guy.

dynavax (dvax)

The DVAX chart is not so bad either.


For “best of breed” top down analysis of all major markets, subscribe to NFTRH Premium, which includes an in-depth weekly market report, detailed interim market updates and NFTRH+ dynamic updates and chart/trade setup ideas. You can also keep up to date with actionable public content at NFTRH.com by using the email form on the right sidebar. Follow via Twitter @NFTRHgt.